Second Asian Consensus on Irritable Bowel Syndrome
- Authors
- Gwee, Kok Ann; Gonlachanvit, Sutep; Ghoshal, Uday C.; Chua, Andrew S. B.; Miwa, Hiroto; Wu, Justin; Bak, Young Tae; Lee, Oh Youn; Lu, Ching-Liang; Park, Hyojin; Chen, Minhu; Syam, Ari F.; Abraham, Philip; Sollano, Jose; Chang, Chi-Sen; Suzuki, Hidekazu; Fang, Xiucai; Fukudo, Shin; Choi, Myung-Gyu; Hou, Xiaohua; Honge, Michio
- Issue Date
- Jul-2019
- Publisher
- 대한소화기 기능성질환∙운동학회
- Keywords
- Asia; Constipation; Diarrhea; Intestines; Irritable bowel syndrome
- Citation
- Journal of Neurogastroenterology and Motility (JNM), v.25, no.3, pp 343 - 362
- Pages
- 20
- Indexed
- SCIE
SCOPUS
KCI
- Journal Title
- Journal of Neurogastroenterology and Motility (JNM)
- Volume
- 25
- Number
- 3
- Start Page
- 343
- End Page
- 362
- URI
- https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/34033
- DOI
- 10.5056/jnm19041
- ISSN
- 2093-0879
2093-0887
- Abstract
- Background/Aims There has been major progress in our understanding of the irritable bowel syndrome (IBS), and novel treatment classes have emerged. The Rome IV guidelines were published in 2016 and together with the growing body of Asian data on IBS, we felt it is timely to update the Asian IBS Consensus. Methods Key opinion leaders from Asian countries were organized into 4 teams to review 4 themes: symptoms and epidemiology, pathophysiology, diagnosis and investigations, and lifestyle modifications and treatments. The consensus development process was carried out by using a modified Delphi method. Results Thirty-seven statements were developed. Asian data substantiate the current global viewpoint that IBS is a disorder of gut-brain interaction. Socio-cultural and environmental factors in Asia appear to influence the greater overlap between IBS and upper gastrointestinal symptoms. New classes of treatments comprising low fermentable oligo-, di-, monosacharides, and polyols diet, probiotics, non-absorbable antibiotics, and secretagogues have good evidence base for their efficacy. Conclusions Our consensus is that all patients with functional gastrointestinal disorders should be evaluated comprehensively with a view to holistic management. Physicians should be encouraged to take a positive attitude to the treatment outcomes for IBS patients.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 2. Clinical Science > Department of Gastroenterology and Hepatology > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.